E. A. Petersen

545 total citations
21 papers, 396 citations indexed

About

E. A. Petersen is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E. A. Petersen has authored 21 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E. A. Petersen's work include Research on Leishmaniasis Studies (4 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). E. A. Petersen is often cited by papers focused on Research on Leishmaniasis Studies (4 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). E. A. Petersen collaborates with scholars based in United States, Denmark and Sudan. E. A. Petersen's co-authors include David Rifkind, Mohammed Siddig, Jon Solomon, Alexander D. Langmuir, C. George Ray, F. A. Neva, J Grayson, H.W. Ghalib, Frances E. Ward and D. Martínez and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

E. A. Petersen

21 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. A. Petersen United States 13 146 124 119 88 49 21 396
M. H. A. Hermans Netherlands 13 107 0.7× 73 0.6× 133 1.1× 66 0.8× 57 1.2× 21 456
Richard J. Kemp Australia 9 84 0.6× 138 1.1× 41 0.3× 85 1.0× 87 1.8× 20 388
P Wertheim Netherlands 10 231 1.6× 49 0.4× 45 0.4× 76 0.9× 60 1.2× 14 430
Dennis O. Gor United States 10 129 0.9× 58 0.5× 66 0.6× 194 2.2× 65 1.3× 12 434
Aziz El Kholy United States 15 141 1.0× 280 2.3× 143 1.2× 76 0.9× 63 1.3× 29 502
Marcelo Antônio Pascoal-Xavier Brazil 13 196 1.3× 127 1.0× 95 0.8× 61 0.7× 56 1.1× 57 436
John Bial United States 9 116 0.8× 245 2.0× 39 0.3× 79 0.9× 127 2.6× 11 603
Sarah Meisner United Kingdom 7 196 1.3× 197 1.6× 252 2.1× 153 1.7× 88 1.8× 11 572
J.-C. Lin Taiwan 14 230 1.6× 23 0.2× 184 1.5× 91 1.0× 101 2.1× 19 681
Béatris Mastelic Switzerland 9 149 1.0× 187 1.5× 81 0.7× 387 4.4× 90 1.8× 9 588

Countries citing papers authored by E. A. Petersen

Since Specialization
Citations

This map shows the geographic impact of E. A. Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. Petersen more than expected).

Fields of papers citing papers by E. A. Petersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. A. Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. Petersen. The network helps show where E. A. Petersen may publish in the future.

Co-authorship network of co-authors of E. A. Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of E. A. Petersen. A scholar is included among the top collaborators of E. A. Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. A. Petersen. E. A. Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Petersen, E. A., et al.. (2024). The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats. The Journal of Prevention of Alzheimer s Disease. 11(4). 1122–1131. 2 indexed citations
3.
Petersen, E. A., et al.. (2024). DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue. International Journal of Obesity. 48(10). 1421–1429. 2 indexed citations
4.
Howard, Michael J., Timothy J. Doyle, Frederick Koster, et al.. (1999). Hantavirus Pulmonary Syndrome in Pregnancy. Clinical Infectious Diseases. 29(6). 1538–1544. 23 indexed citations
5.
Petersen, E. A., et al.. (1996). Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model. Journal of Antimicrobial Chemotherapy. 38(5). 819–828. 24 indexed citations
6.
Petersen, E. A., C H Ramírez-Ronda, William D. Hardy, et al.. (1995). Dose-Related Activity Of Stavudine In Patients Infected With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 171(Supplement 2). S131–S139. 48 indexed citations
7.
Siddig, Mohammed, et al.. (1994). The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Clinical & Experimental Immunology. 95(2). 294–299. 44 indexed citations
8.
Siddig, Mohammed, et al.. (1990). Visceral leishmaniasis in Sudan. Clinical features.. PubMed. 42(2). 107–12. 26 indexed citations
9.
Hersh, E. M., et al.. (1990). Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group.. PubMed. 72. 355–63. 3 indexed citations
10.
Hersh, E., et al.. (1988). Immunological Characteristics and Potential Approaches to Immunotherapy of HIV Infection. Recent results in cancer research. 112. 17–26. 1 indexed citations
11.
Langmuir, Alexander D., et al.. (1985). The Thucydides Syndrome. New England Journal of Medicine. 313(16). 1027–1030. 48 indexed citations
12.
Petersen, E. A. & F. A. Neva. (1984). MONOCYTE SUPPRESSION OF ANTIGEN SPECIFIC RESPONSES IN DIFFUSE CUTANEOUS LEISHMANIASIS PATIENTS, DOMINICAN REPUBLIC. 132. 2603–2603. 3 indexed citations
13.
Petersen, E. A., et al.. (1984). Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic.. The Journal of Immunology. 132(5). 2603–2606. 42 indexed citations
14.
Petersen, E. A., et al.. (1981). Murine transfer factor. I. Description of the model and evidence for specificity.. The Journal of Immunology. 126(6). 2480–2484. 17 indexed citations
15.
Kirkpatrick, Charles H., et al.. (1980). Treatment of Chronic Mucocutaneous Candidosis with Ketoconazole: Preliminary Results of a Controlled, Double-Blind Clinical Trial. Clinical Infectious Diseases. 2(4). 599–599. 13 indexed citations
16.
Rifkind, David, et al.. (1977). Transfer of delayed hypersensitivity in mice to microbial antigens with dialyzable transfer factor. Infection and Immunity. 16(1). 258–262. 29 indexed citations
17.
Rifkind, David, et al.. (1976). Delayed Hypersensitivity to Fungal Antigens in Mice. I. Use of the Intradermal Skin and Footpad Swelling Tests as Assays of Active and Passive Sensitization. The Journal of Infectious Diseases. 133(1). 50–56. 18 indexed citations
18.
Rifkind, David, et al.. (1976). Delayed Hypersensitivity to Fungal Antigens in Mice. III. Characterization of the Active Component in Immunogenic RNA Extracts. The Journal of Infectious Diseases. 133(5). 533–537. 8 indexed citations
19.
Petersen, E. A., et al.. (1975). VARICELLA FOLLOWED BY GLOMERULONEPHRITIS. Acta Paediatrica. 64(6). 886–890. 13 indexed citations
20.
Petersen, E. A., et al.. (1960). [Renal hamartoma diagnosed in vivo].. PubMed. 64. 1099–101. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026